XBiotech Inc. SEC filings XBIT

XBiotech Inc. has 407 filings in SEC EDGAR's recent list, going back to Dec 10, 2014. Its latest annual report, Form ARS, was filed on Oct 2, 2026 for the period ended Oct 2, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on December 31.

XBiotech Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 26, 2026 Oct 23, 2026
ARS Annual report to shareholders Oct 2, 2026 Oct 2, 2026
DEF 14A Proxy statement Oct 2, 2026 Nov 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 13, 2026 Dec 31, 2025
S-8 Employee stock plan registration Mar 11, 2026 —
8-K Current report
Officer or director change
Dec 9, 2025 Dec 5, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K/A Amended current report
Officer or director change
Oct 15, 2025 Jun 24, 2025
8-K Current report
Material agreement, Officer or director change
Oct 3, 2025 Oct 1, 2025
8-K Current report
Shareholder vote results
Sep 2, 2025 Aug 29, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
ARS Annual report to shareholders Jul 7, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 7, 2025 Aug 29, 2025
8-K Current report
Officer or director change
Jun 24, 2025 Jun 24, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
8-K Current report
Listing notice
Apr 7, 2025 Apr 1, 2025
8-K Current report
Officer or director change
Apr 1, 2025 Mar 27, 2025
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Dec 31, 2024 Dec 31, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 20, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
ARS Annual report to shareholders May 1, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 1, 2024 —
DEF 14A Proxy statement May 1, 2024 Jun 20, 2024
10-K/A Amended annual report May 1, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 24, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 4, 2024 Jan 3, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 23, 2023
SC TO-I/A Filing Jun 20, 2023 —
SC TO-I Filing May 17, 2023 —
10-Q Quarterly report May 10, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 23, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Feb 15, 2023 Feb 3, 2023
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 29, 2022 Jun 22, 2022
DEFA14A Additional proxy material May 13, 2022 —
DEF 14A Proxy statement May 13, 2022 Jun 22, 2022
8-K Current report
Auditor change
May 13, 2022 May 11, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
8-K Current report
Material agreement
Feb 2, 2022 Feb 2, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Other events
Jul 6, 2021 Jul 6, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 29, 2021 —
DEF 14A Proxy statement Apr 29, 2021 Jun 22, 2021
10-K Annual report Mar 16, 2021 Dec 31, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
S-8 Employee stock plan registration Oct 2, 2020 —
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Shareholder vote results
Jun 29, 2020 Jun 26, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 26, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
SC TO-I/A Filing Feb 19, 2020 —
SC TO-I/A Filing Feb 13, 2020 —
SC TO-I/A Filing Feb 13, 2020 —
SC TO-I/A Filing Feb 5, 2020 —
SC TO-I Issuer tender offer statement Jan 14, 2020 —
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Dec 30, 2019 Dec 30, 2019
8-K Current report
Material agreement, Other events
Dec 9, 2019 Dec 7, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Officer or director change, Other events
Jul 16, 2019 Jul 10, 2019
8-K Current report
Shareholder vote results
Jun 20, 2019 Jun 19, 2019
8-K Current report
Material agreement, Other events
Jun 3, 2019 May 31, 2019
424B5 Prospectus supplement Jun 3, 2019 —
S-3MEF Form s-3 May 31, 2019 —
424B5 Prospectus supplement May 31, 2019 —
8-K Current report
Other events
May 30, 2019 May 30, 2019
8-K Current report
Agreement ended
May 30, 2019 May 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Material agreement
May 1, 2019 Apr 30, 2019
424B5 Prospectus supplement May 1, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 19, 2019
8-K Current report
Agreement ended
Apr 3, 2019 Mar 29, 2019
10-K/A Amended annual report Mar 15, 2019 Dec 31, 2018
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-Q Quarterly report Oct 31, 2018 Sep 30, 2018
8-K Current report
Other events
Oct 24, 2018 Oct 24, 2018
UPLOAD Letter from the SEC Oct 1, 2018 —
10-K/A Amended annual report Sep 5, 2018 Dec 31, 2017
10-Q/A Amended quarterly report Sep 5, 2018 Mar 31, 2018
CORRESP Letter to the SEC Sep 4, 2018 —
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
UPLOAD Letter from the SEC Aug 6, 2018 —
10-K/A Amended annual report Jul 31, 2018 Dec 31, 2017
10-Q/A Amended quarterly report Jul 31, 2018 Mar 31, 2018
CORRESP Letter to the SEC Jul 31, 2018 —
UPLOAD Letter from the SEC Jul 24, 2018 —
8-K Current report
Shareholder vote results
Jun 21, 2018 Jun 19, 2018
10-Q Quarterly report May 8, 2018 Mar 31, 2018
DEFA14A Additional proxy material Apr 30, 2018 —
DEF 14A Proxy statement Apr 30, 2018 Apr 30, 2018
8-K Current report
Officer or director change, Other events
Apr 11, 2018 Apr 9, 2018
8-K Current report
Other events
Mar 23, 2018 Mar 23, 2018
8-K Current report
Officer or director change
Mar 22, 2018 Mar 20, 2018
10-K Annual report Mar 16, 2018 Dec 31, 2017
8-K Current report
Officer or director change, Other events
Mar 1, 2018 Feb 27, 2018
8-K Current report
Listing notice, Officer or director change
Jan 19, 2018 Jan 16, 2018
8-K Current report
Other events
Jan 5, 2018 Jan 5, 2018
8-K Current report
Other events
Nov 22, 2017 Nov 20, 2017
10-Q Quarterly report Nov 9, 2017 Nov 2, 2017
8-K Current report
Other events
Sep 15, 2017 Sep 14, 2017
10-Q Quarterly report Aug 8, 2017 Jun 30, 2017
8-K Current report
Shareholder vote results
Jun 20, 2017 Jun 19, 2017
8-K Current report
Other events
Jun 9, 2017 Jun 9, 2017
8-K Current report
Other events
May 18, 2017 May 18, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
DEFA14A Additional proxy material Apr 28, 2017 —
DEF 14A Proxy statement Apr 28, 2017 Jun 19, 2017
8-K Current report
Other events
Apr 28, 2017 Apr 28, 2017
8-K Current report
Other events
Apr 21, 2017 Apr 20, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
8-K Current report
Material agreement, Regulation FD disclosure
Mar 3, 2017 Mar 3, 2017
424B5 Prospectus supplement Mar 3, 2017 —
8-K Current report
Other events
Feb 8, 2017 Feb 8, 2017
8-K Current report
Other events
Dec 16, 2016 Dec 16, 2016
8-K/A Amended current report Dec 7, 2016 Dec 5, 2016
8-K/A Amended current report Dec 6, 2016 Dec 5, 2016
8-K Current report
Other events
Dec 5, 2016 Dec 5, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
8-K Current report
Material agreement
Sep 26, 2016 Sep 26, 2016
424B5 Prospectus supplement Sep 26, 2016 —
EFFECT Filing Sep 1, 2016 —
CORRESP Letter to the SEC Aug 30, 2016 —
UPLOAD Letter from the SEC Aug 26, 2016 —
S-3 Shelf registration Aug 19, 2016 —
10-Q Quarterly report Aug 12, 2016 Jun 30, 2016
8-K Current report
Shareholder vote results
Jun 21, 2016 Jun 20, 2016
DEFA14A Additional proxy material May 25, 2016 —
8-K Current report
Other events
May 24, 2016 May 24, 2016
10-Q Quarterly report May 13, 2016 Mar 31, 2016
8-K Current report
Officer or director change
May 3, 2016 May 2, 2016
DEFA14A Additional proxy material Apr 29, 2016 —
DEF 14A Proxy statement Apr 29, 2016 Jun 20, 2016
10-K/A Amended annual report Apr 15, 2016 Dec 31, 2015
10-K Annual report Mar 30, 2016 Dec 31, 2015
8-K Current report
Regulation FD disclosure, Other events
Jan 8, 2016 Jan 8, 2016
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
S-8 Employee stock plan registration Oct 19, 2015 —
10-Q Quarterly report Aug 14, 2015 Jun 30, 2015
8-K Current report
Results of operations
Jul 29, 2015 Jul 28, 2015
8-K Current report
Other events
Jul 16, 2015 Jul 15, 2015
8-K Current report
Other events
Jul 1, 2015 Jul 1, 2015
10-Q/A Amended quarterly report Jun 18, 2015 Mar 31, 2015
8-K Current report
Officer or director change
Jun 11, 2015 Jun 8, 2015
8-K Current report
Other events
Jun 2, 2015 May 28, 2015
8-K Current report
Other events
May 29, 2015 May 26, 2015
10-Q/A Amended quarterly report May 29, 2015 Mar 31, 2015
10-Q Quarterly report May 27, 2015 Mar 31, 2015
8-K Current report
Other events
May 19, 2015 May 18, 2015
8-K Current report
Officer or director change, Other events
May 5, 2015 Apr 29, 2015
8-K Current report
Other events
Apr 20, 2015 Apr 17, 2015
424B4 Prospectus Apr 16, 2015 —
CT ORDER Filing Apr 15, 2015 —
CERTNAS Auto-generated paper document Apr 14, 2015 —
EFFECT Filing Apr 14, 2015 —
8-A12B Form 8-a12b Apr 14, 2015 —
CORRESP Letter to the SEC Apr 10, 2015 —
CORRESP Letter to the SEC Apr 10, 2015 —
S-1/A Amended registration statement Apr 10, 2015 —
CORRESP Letter to the SEC Apr 9, 2015 —
UPLOAD Letter from the SEC Apr 7, 2015 —
FWP Free writing prospectus Mar 27, 2015 —
FWP Free writing prospectus Mar 27, 2015 —
CORRESP Letter to the SEC Mar 27, 2015 —
S-1/A Amended registration statement Mar 27, 2015 —
UPLOAD Letter from the SEC Mar 24, 2015 —
CORRESP Letter to the SEC Mar 20, 2015 —
CORRESP Letter to the SEC Mar 10, 2015 —
S-1/A Amended registration statement Mar 10, 2015 —
UPLOAD Letter from the SEC Feb 12, 2015 —
CORRESP Letter to the SEC Feb 2, 2015 —
S-1 Registration statement Feb 2, 2015 —
UPLOAD Letter from the SEC Jan 9, 2015 —
DRS Filing Dec 10, 2014 —

Showing 192 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XBIT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1626878

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.